• 1竞技官网

    科学文献

    我们与学术机构开展合作研究,以评估我们的管线产品。以下是发表的相关文献。

    年:

    Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

    Sundar Jagannath, Thomas G Martin, Yi Lin, Adam D Cohen […]

    Real-World Treatment Patterns and Outcomes in Patients With Lenalidomide-Refractory Multiple Myeloma With 1 to 3 Prior Lines: SEER-Medicare Database

    Binod Dhakal, Jinghua He, Jordan M Schecter, William De […]

    Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison

    Noemi Puig, Joris Diels, Suzy van Sanden, João Mendes,H […]

    CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma

    Simon J Harrison, Cyrille Touzeau, Nicolas Kint, Kather […]

    Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial

    Roberto Mina, Anne K Mylin, Hisayuki Yokoyama, Hila Mag […]

    您即将离开我们的网站

    本网站使用Cookies来改善您的整体体验,让您下次访问网站时更加轻松快捷,为您带来更好的服务。具体内容请参阅 隐私政策 Cookie政策